Daniel O’Day, Gilead chairman and CEO (Photo by Jim Watson/AFP via Getty Images)
Gilead leads HIV grantmakers list, tops Gates Foundation in a first for annual survey
Gilead Sciences’ $100 million pledge to fight the HIV epidemic in the southern US states helped boost the biopharma to the top of an annual …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
